Kyto Biopharma Inc Stock Other OTC
Equities
US5015721013
Financial & Commodity Market Operators
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2020 | 0.01 | Sales 2021 | - | Capitalization | 18.62M |
---|---|---|---|---|---|
Net income 2020 | - | Net income 2021 | - | EV / Sales 2020 | 926,138,940 x |
Net cash position 2020 | 28.01K | Net cash position 2021 | 8.26M | EV / Sales 2021 | - |
P/E ratio 2020 |
-17
x | P/E ratio 2021 |
95
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 53.62% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Russo
CEO | Chief Executive Officer | 81 | 99-03-04 |
Director of Finance/CFO | 75 | 18-03-14 | |
Investor Relations Contact | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Russo
CEO | Chief Executive Officer | 81 | 99-03-04 |
Peter Staple
BRD | Director/Board Member | 72 | 21-01-07 |
Jon Saxe
BRD | Director/Board Member | 88 | 21-01-07 |
1st Jan change | Capi. | |
---|---|---|
+2.55% | 75.59B | |
-3.67% | 59.36B | |
-6.64% | 39.87B | |
-2.06% | 35.98B | |
+3.41% | 34.96B | |
-22.89% | 11.76B | |
+7.31% | 9.29B | |
-31.09% | 7.58B | |
-5.29% | 7.32B |